These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 37506683)

  • 1. Temporally Associated Invasive Pneumococcal Disease and SARS-CoV-2 Infection, Alaska, USA, 2020-2021.
    Newell K; Fischer M; Massey S; Orell L; Steinberg J; Tompkins M; Castrodale L; McLaughlin J
    Emerg Infect Dis; 2023 Sep; 29(9):1765-1771. PubMed ID: 37506683
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Invasive Pneumococcal Disease and Potential Impact of Pneumococcal Conjugate Vaccines Among Adults, Including Persons Experiencing Homelessness-Alaska, 2011-2020.
    Steinberg J; Bressler SS; Orell L; Thompson GC; Kretz A; Reasonover AL; Bruden D; Bruce MG; Fischer M
    Clin Infect Dis; 2024 Jan; 78(1):172-178. PubMed ID: 37787072
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of the Coronavirus Disease 2019 (COVID-19) Pandemic on Invasive Pneumococcal Disease and Risk of Pneumococcal Coinfection With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): Prospective National Cohort Study, England.
    Amin-Chowdhury Z; Aiano F; Mensah A; Sheppard CL; Litt D; Fry NK; Andrews N; Ramsay ME; Ladhani SN
    Clin Infect Dis; 2021 Mar; 72(5):e65-e75. PubMed ID: 33196783
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Invasive pneumococcal disease epidemiology and effectiveness of 23-valent pneumococcal polysaccharide vaccine in Alaska native adults.
    Singleton RJ; Butler JC; Bulkow LR; Hurlburt D; O'Brien KL; Doan W; Parkinson AJ; Hennessy TW
    Vaccine; 2007 Mar; 25(12):2288-95. PubMed ID: 17254673
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of the 13-valent pneumococcal conjugate vaccine (pcv13) on invasive pneumococcal disease and carriage in Alaska.
    Bruce MG; Singleton R; Bulkow L; Rudolph K; Zulz T; Gounder P; Hurlburt D; Bruden D; Hennessy T
    Vaccine; 2015 Sep; 33(38):4813-9. PubMed ID: 26247901
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Invasive Pneumococcal Disease diminish during the onset of COVID-19 in Japan between 2019 and 2022.
    Khongyot T; Moriyasu T
    Int J Infect Dis; 2022 Sep; 122():307-309. PubMed ID: 35671951
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decline in Pneumococcal Disease in Young Children During the Coronavirus Disease 2019 (COVID-19) Pandemic in Israel Associated With Suppression of Seasonal Respiratory Viruses, Despite Persistent Pneumococcal Carriage: A Prospective Cohort Study.
    Danino D; Ben-Shimol S; van der Beek BA; Givon-Lavi N; Avni YS; Greenberg D; Weinberger DM; Dagan R
    Clin Infect Dis; 2022 Aug; 75(1):e1154-e1164. PubMed ID: 34904635
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of Nonpharmaceutical Interventions During the COVID-19 Pandemic With Invasive Pneumococcal Disease, Pneumococcal Carriage, and Respiratory Viral Infections Among Children in France.
    Rybak A; Levy C; Angoulvant F; Auvrignon A; Gembara P; Danis K; Vaux S; Levy-Bruhl D; van der Werf S; Béchet S; Bonacorsi S; Assad Z; Lazzati A; Michel M; Kaguelidou F; Faye A; Cohen R; Varon E; Ouldali N
    JAMA Netw Open; 2022 Jun; 5(6):e2218959. PubMed ID: 35763298
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Re-emergence of invasive pneumococcal disease (IPD) and increase of serotype 23B after easing of COVID-19 measures, Switzerland, 2021.
    Casanova C; Küffer M; Leib SL; Hilty M
    Emerg Microbes Infect; 2021 Dec; 10(1):2202-2204. PubMed ID: 34723783
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recurrent invasive pneumococcal disease in children--host factors and vaccination response.
    Ingels HA
    Dan Med J; 2015 Jul; 62(7):. PubMed ID: 26183055
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outbreak of invasive pneumococcal disease--Alaska, 2003-2004.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2005 Jan; 54(3):72-5. PubMed ID: 15674187
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidemiology, vaccine effectiveness, and risk factors for mortality for pneumococcal disease among hospitalised adults in Singapore: a case-control study.
    Chan T; Tay MZ; Kyaw WM; Chow A; Ho HJ
    BMC Infect Dis; 2020 Jun; 20(1):423. PubMed ID: 32552726
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reemergence of Invasive Pneumococcal Disease in Germany During the Spring and Summer of 2021.
    Perniciaro S; van der Linden M; Weinberger DM
    Clin Infect Dis; 2022 Sep; 75(7):1149-1153. PubMed ID: 35136983
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The incremental burden of invasive pneumococcal disease associated with a decline in childhood vaccination using a dynamic transmission model in Japan: A secondary impact of COVID-19.
    Kitano T; Aoki H
    Comput Biol Med; 2021 Jun; 133():104429. PubMed ID: 33930765
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Invasive pneumococcal disease caused by nonvaccine serotypes among alaska native children with high levels of 7-valent pneumococcal conjugate vaccine coverage.
    Singleton RJ; Hennessy TW; Bulkow LR; Hammitt LL; Zulz T; Hurlburt DA; Butler JC; Rudolph K; Parkinson A
    JAMA; 2007 Apr; 297(16):1784-92. PubMed ID: 17456820
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk for Invasive Streptococcal Infections among Adults Experiencing Homelessness, Anchorage, Alaska, USA, 2002-2015.
    Mosites E; Zulz T; Bruden D; Nolen L; Frick A; Castrodale L; McLaughlin J; Van Beneden C; Hennessy TW; Bruce MG
    Emerg Infect Dis; 2019 Oct; 25(10):1911-8. PubMed ID: 31538562
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular epidemiology of serotype 19A Streptococcus pneumoniae among invasive isolates from Alaska, 1986-2010.
    Rudolph K; Bruce MG; Bulkow L; Zulz T; Reasonover A; Harker-Jones M; Hurlburt D; Hennessy TW
    Int J Circumpolar Health; 2013; 72():. PubMed ID: 23984273
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Streptococcus pneumoniae non-susceptibility and outpatient antimicrobial prescribing rates at the Alaska Native Medical Center.
    Stevens RW; Wenger J; Bulkow L; Bruce MG
    Int J Circumpolar Health; 2013; 72():22297. PubMed ID: 24358456
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changing epidemiology of invasive pneumococcal disease among White Mountain Apache persons in the era of the pneumococcal conjugate vaccine.
    Lacapa R; Bliss SJ; Larzelere-Hinton F; Eagle KJ; McGinty DJ; Parkinson AJ; Santosham M; Craig MJ; O'Brien KL
    Clin Infect Dis; 2008 Aug; 47(4):476-84. PubMed ID: 18627249
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Invasive pneumococcal disease in Alaskan children: impact of the seven-valent pneumococcal conjugate vaccine and the role of water supply.
    Wenger JD; Zulz T; Bruden D; Singleton R; Bruce MG; Bulkow L; Parks D; Rudolph K; Hurlburt D; Ritter T; Klejka J; Hennessy T
    Pediatr Infect Dis J; 2010 Mar; 29(3):251-6. PubMed ID: 19952861
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.